African Trypanosomiasis
📧 Sign up to get email alerts when something new happens for African Trypanosomiasis.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2023-12-13FDA Approved: IWILFIN — Original Application (USWM, LLC)
The FDA approved IWILFIN (eflornithine hydrochloride) under an original NDA from USWM, LLC.
-
FDA approval · 2022-03-17FDA Approved: PENTAMIDINE ISETHIONATE — Original Application (XGen Pharmaceuticals DJB, Inc.)
FDA approved the original application for Pentamidine isethionate (generic) from XGen Pharmaceuticals DJB, Inc., authorizing its U.S. market…
-
CLINICAL_TRIALS trial_result · 2015-10-08Clinical Trial Update: Bioequivalence Study - Reference Clinical Fexinidazole Tablet Versus Proposed Market Formulation [Phase 1]
This Phase 1 trial evaluated bioequivalence between a reference fexinidazole tablet and the proposed market formulation for African trypanos…
-
CLINICAL_TRIALS trial_result · 2008-12-08Clinical Trial Update: Trial of DB289 for the Treatment of Stage I African Trypanosomiasis [Phase 2]
Phase 2 trial update for DB289 in Stage I African trypanosomiasis has been completed.